Disturbances in the mineral metabolism and parathyroid hormone (PTH)–vitamin D endocrine loop are prevalent in patients with advanced chronic kidney disease (CKD) and typically leads to bone abnormalities in turnover, mineralization, volume, and strength—which is also known as “CKD-MBD (mineral and bone disorders)”1,2. This evidence concerns the gene PTH and bone disorder.